Cargando…

Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo

Rheumatoid arthritis (RA) is a debilitating and painful inflammatory autoimmune disease characterised by the accumulation of leukocytes in the synovium, cartilage destruction and bone erosion. The immunomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) has been widely studied a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Fiona K., Stefan, Andrei, Kay, Alasdair G., Hyland, Mairead, Morgan, Rebecca, Forsyth, Nicholas R., Pisconti, Addolorata, Kehoe, Oksana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686503/
https://www.ncbi.nlm.nih.gov/pubmed/33235244
http://dx.doi.org/10.1038/s41598-020-77514-z
_version_ 1783613341785128960
author Jones, Fiona K.
Stefan, Andrei
Kay, Alasdair G.
Hyland, Mairead
Morgan, Rebecca
Forsyth, Nicholas R.
Pisconti, Addolorata
Kehoe, Oksana
author_facet Jones, Fiona K.
Stefan, Andrei
Kay, Alasdair G.
Hyland, Mairead
Morgan, Rebecca
Forsyth, Nicholas R.
Pisconti, Addolorata
Kehoe, Oksana
author_sort Jones, Fiona K.
collection PubMed
description Rheumatoid arthritis (RA) is a debilitating and painful inflammatory autoimmune disease characterised by the accumulation of leukocytes in the synovium, cartilage destruction and bone erosion. The immunomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) has been widely studied and the recent observations that syndecan-3 (SDC3) is selectively pro-inflammatory in the joint led us to hypothesise that SDC3 might play an important role in MSC biology. MSCs isolated from bone marrow of wild type and Sdc3(−/−) mice were used to assess immunophenotype, differentiation, adhesion and migration properties and cell signalling pathways. While both cell types show similar differentiation potential and forward scatter values, the cell complexity in wild type MSCs was significantly higher than in Sdc3(−/−) cells and was accompanied by lower spread surface area. Moreover, Sdc3(−/−) MSCs adhered more rapidly to collagen type I and showed a dramatic increase in AKT phosphorylation, accompanied by a decrease in ERK1/2 phosphorylation compared with control cells. In a mouse model of antigen-induced inflammatory arthritis, intraarticular injection of Sdc3(−/−) MSCs yielded enhanced efficacy compared to injection of wild type MSCs. In conclusion, our data suggest that syndecan-3 regulates MSC adhesion and efficacy in inflammatory arthritis, likely via induction of the AKT pathway.
format Online
Article
Text
id pubmed-7686503
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76865032020-11-27 Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo Jones, Fiona K. Stefan, Andrei Kay, Alasdair G. Hyland, Mairead Morgan, Rebecca Forsyth, Nicholas R. Pisconti, Addolorata Kehoe, Oksana Sci Rep Article Rheumatoid arthritis (RA) is a debilitating and painful inflammatory autoimmune disease characterised by the accumulation of leukocytes in the synovium, cartilage destruction and bone erosion. The immunomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) has been widely studied and the recent observations that syndecan-3 (SDC3) is selectively pro-inflammatory in the joint led us to hypothesise that SDC3 might play an important role in MSC biology. MSCs isolated from bone marrow of wild type and Sdc3(−/−) mice were used to assess immunophenotype, differentiation, adhesion and migration properties and cell signalling pathways. While both cell types show similar differentiation potential and forward scatter values, the cell complexity in wild type MSCs was significantly higher than in Sdc3(−/−) cells and was accompanied by lower spread surface area. Moreover, Sdc3(−/−) MSCs adhered more rapidly to collagen type I and showed a dramatic increase in AKT phosphorylation, accompanied by a decrease in ERK1/2 phosphorylation compared with control cells. In a mouse model of antigen-induced inflammatory arthritis, intraarticular injection of Sdc3(−/−) MSCs yielded enhanced efficacy compared to injection of wild type MSCs. In conclusion, our data suggest that syndecan-3 regulates MSC adhesion and efficacy in inflammatory arthritis, likely via induction of the AKT pathway. Nature Publishing Group UK 2020-11-24 /pmc/articles/PMC7686503/ /pubmed/33235244 http://dx.doi.org/10.1038/s41598-020-77514-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jones, Fiona K.
Stefan, Andrei
Kay, Alasdair G.
Hyland, Mairead
Morgan, Rebecca
Forsyth, Nicholas R.
Pisconti, Addolorata
Kehoe, Oksana
Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title_full Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title_fullStr Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title_full_unstemmed Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title_short Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo
title_sort syndecan-3 regulates msc adhesion, erk and akt signalling in vitro and its deletion enhances msc efficacy in a model of inflammatory arthritis in vivo
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686503/
https://www.ncbi.nlm.nih.gov/pubmed/33235244
http://dx.doi.org/10.1038/s41598-020-77514-z
work_keys_str_mv AT jonesfionak syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT stefanandrei syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT kayalasdairg syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT hylandmairead syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT morganrebecca syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT forsythnicholasr syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT piscontiaddolorata syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo
AT kehoeoksana syndecan3regulatesmscadhesionerkandaktsignallinginvitroanditsdeletionenhancesmscefficacyinamodelofinflammatoryarthritisinvivo